Coverage for new oral cancer drugs

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2001年 / 15卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：673 / 673
页数：1
相关论文
共 50 条
  • [1] USE OF ORAL CHEMOTHERAPY DRUGS AND FALLING INTO THE COVERAGE GAP IN MEDICARE CANCER SURVIVORS
    Yuan, J.
    Lu, K. Z.
    Wu, J.
    VALUE IN HEALTH, 2017, 20 (05) : A368 - A368
  • [2] New Oral Anti-Cancer Drugs and Medication Safety
    Schlichtig, Katja
    Duerr, Pauline
    Doerje, Frank
    Fromm, Martin F.
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2019, 116 (46): : 775 - +
  • [3] Oral fluoropyrimidines among the new drugs for patients with metastatic breast cancer
    R C F Leonard
    British Journal of Cancer, 2001, 84 : 1437 - 1442
  • [4] Cancer drugs - management of oral cancer therapy - a new role and responsibility for primary care
    Grossenbacher-Villiger, M.
    Bachmann-Mettler, I
    Kraehenbuehl, S.
    Nadig, J.
    SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 16S - 16S
  • [5] New oral antidiabetic drugs
    Mueller-Wieland, Dirk
    Schuett, Katharina
    Brandts, Julia
    Marx, Nikolaus
    HERZ, 2020, 45 (05) : 493 - 503
  • [6] New Oral Drugs for Migraine
    Nazia Karsan
    Peter J. Goadsby
    CNS Drugs, 2022, 36 : 933 - 949
  • [7] New oral anticoagulant drugs
    Berkovits, Alejandro
    Aizman, Andres
    Zuniga, Pamela
    Pereira, Jaime
    Mezzano, Diego
    REVISTA MEDICA DE CHILE, 2011, 139 (10) : 1347 - 1355
  • [8] New Oral Drugs for Migraine
    Karsan, Nazia
    Goadsby, Peter J.
    CNS DRUGS, 2022, 36 (09) : 933 - 949
  • [9] New oral drugs in MS
    Comi, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 5 - 5
  • [10] THE NEW ORAL ANTIDIABETIC DRUGS
    MOSS, JM
    DELAWTER, DE
    AMERICAN FAMILY PHYSICIAN, 1984, 30 (05) : 119 - 121
12345